Literature DB >> 10968949

Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.

A L Moreira1, L Tsenova, P J Murray, S Freeman, A Bergtold, L Chiriboga, G Kaplan.   

Abstract

To better understand the contribution of interferon-gamma (IFN-gamma) to the immune response during the first 60 days of mycobacterial infection in the lungs, IFN-gamma gene disrupted (IFN-gamma-/-) mice were infected via aerosol with recombinant Mycobacterium bovis Bacillus Calmette-Guerin (BCG) secreting murine IFN-gamma (BCG-IFN-gamma) and compared to mice infected with recombinant BCG containing the vector only (BCG-vector). When IFN-gamma-/- mice were infected with BCG-vector, increasing bacillary loads and large undifferentiated granulomas that did not express inducible nitric oxide synthase (iNOS) were observed in the lungs. In contrast, infection with BCG-IFN-gamma resulted in reduced bacillary load and better differentiated granulomas containing epithelioid macrophages expressing iNOS as well as reduced levels of interleukin 10 (IL-10) mRNA. However, local production of IFN-gamma by the recombinant BCG did not protect IFN-gamma-/- mice from subsequent challenge with M. tuberculosis. Infection of IFN-gamma-/- peritoneal macrophages in vitro with BCG-IFN-gamma led to induction of iNOS expression and lower IL-10 mRNA levels. Nevertheless, the growth of the intracellular BCG was unaffected. Since IFN-gamma induced-iNOS protein and reduced IL-10 production were insufficient to control mycobacterial growth in vitro, the results suggest that additional mediator(s) present in vivo are required for control of mycobacterial growth. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968949     DOI: 10.1006/mpat.2000.0382

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  15 in total

Review 1.  The many faces of host responses to tuberculosis.

Authors:  H L Collins; S H Kaufmann
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Natural killer T cells suppress zymosan A-mediated granuloma formation in the liver by modulating interferon-γ and interleukin-10.

Authors:  Takahiro Kobayashi; Hiroki Kawamura; Yasuhiro Kanda; Hiroaki Matsumoto; Suguru Saito; Kazuyoshi Takeda; Toshihiko Kawamura; Toru Abo
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Host genome polymorphisms and tuberculosis infection: What we have to say?

Authors:  Said Alfin Khalilullah; Harapan Harapan; Nabeeh A Hasan; Wira Winardi; Ichsan Ichsan; Mulyadi Mulyadi
Journal:  Egypt J Chest Dis Tuberc       Date:  2013-12-17

4.  Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.

Authors:  L G Bekker; A L Moreira; A Bergtold; S Freeman; B Ryffel; G Kaplan
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 5.  Recombinant BCG as a vaccine vehicle to protect against tuberculosis.

Authors:  James A Triccas
Journal:  Bioeng Bugs       Date:  2009-11-02

6.  Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.

Authors:  Marcia A Firmani; Lee W Riley
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.

Authors:  Bindu Raju; Yoshihiko Hoshino; Kenichi Kuwabara; Ilana Belitskaya; Savita Prabhakar; Antony Canova; Jeffrey A Gold; Rany Condos; Richard I Pine; Stuart Brown; William N Rom; Michael D Weiden
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

9.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

Review 10.  Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.

Authors:  Yi Luo; Jonathan Henning; Michael A O'Donnell
Journal:  Clin Dev Immunol       Date:  2011-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.